Stelerix Web Blog Knowledge at your Fingertips

8Feb/110

Funding Initiatives and Analytical Applications.

As promised, here is the full summary and video transcript of my recent interview with Dr. Gregory Weiss.

Feel free to submit follow-up questions or start a discussion.

If you want to contribute to an upcoming interview or suggest someone as a candidate because of interesting thought-leading work, please contact us or leave a comment here!

Posted by Jeff

12Jan/110

Exclusive Interview, Part 2

I woke up at 3:30am (2:00pm IST) the other day, to find out about lessons learned  in competitive generic global product launches.

The follow-up to our first exclusive interview is now online.

Watch this FREE, on-demand webinar to understand:

  • What the Indian market will look like in ten years
  • What differentiates it from
  • Strategies for generics success.
  • How to deal with regulatory hurdles and surprises.

It's our first attempt at supplementing an audio call with powerpoint presentations and a full minute-by-minute note-guide. We are very eager to improve and should have a version with improved sound quality up by tomorrow. Your comments and thoughts are encouraged.

FREE On-Demand Webinar - Alok Kumar discusses what is required for generics success in India, and the world.

Posted by Jeff

6Jan/110

Merck Moves In

It is always encouraging to see the big players making aggressive moves into a market. The announcement then, that Merck KgaA is setting up an Indian technology centre to provide contract development services for a large range of applications, is exactly what we like to hear. That it's part of an ongoing initiative is even more exciting.

Some of Merck's other innovative initiatives, such as the one below, present very interesting soft opportunities that will also benefit rising executives in emerging markets. And not just in job-specific technical roles. Access to the seasoned experiences of others is something that we predicate our own business on (see: interviews with experts) and another hidden benefit of globalization.

Posted by Jeff

UPDATE: Brought to our attention by our good friend, @andrealmarch is this fantastic Globe and Mail article: Ten tips for success in India

24Dec/100

Trade Traction.

45% of India's USD 22 billiion pharmaceutical industry obtains revenue from exporting generic drugs. Understandably then, it's exciting to see progress in India's trade spat with the EU over generic drugs.

With so much on the line, it makes sense why resolution is important. And an admission of guilt by the EU at this month's Brussels Summit is a concrete and promising step forward.

15Nov/100

Unlocking India – Upcoming Webinar Series

Thanks for stopping by. Here is what we are focusing on, currently. Each blurb is a 2-3 hour webinar. After you read it, can you let us know what specifically you would be most interested in hearing about? Please?

“Mr. Nitin Parab assembles a trio of key opinion leaders for an interactive, case-study driven discussion. Achieve seamless regulatory compliance and ensure accelerated approval and market penetration as Nitin works with leading USFDA and EDQM experts.”

“Dr. Varma is a key player in a wide network of experts, who consistently craft successful contract-manufacturing agreements, and reap the benefits. Partake in an interactive discussion. Overcome common hurdles. Cut costs, drastically. Create effective and scalable strategic alliances with qualified local partners.”

“Hear from the architect of a record global licensing and distribution deal. Mr. Alok Kumar explains how to thrive in a fragmented market, wherein 10,000 companies vie for 70% of market share. He is the undeniable expert, when it comes to implementing immensely profitable alliances.”

“Dr. Anantharaman and three of his leading industry peers will provide an in-depth analysis of what is required for maximum market access. Specific emphasis will be placed on how scientific and evidence-based marketing strategies have been used as a significant driver of market share in a fragmented and tumultuous Indian market”

Thanks for reading. So, what do you think?

Tell us how we can refine this content. What information would make a webinar worth your while? Think about it! We can do this for you!

Answer here.

To request more information about attending these webinars, scalable advertising, or to subscribe to our newsletter, email: info@stelerix.com

Follow: @stelerix